velagliflozin (Senvelgo)
Jump to navigation
Jump to search
Indications
- diabetes mellitus type 2 alone or with other agents in horses & ponies
Dosage
More general terms
References
- ↑ Meier A, de Laat M, Reiche D et al The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies. BMC Vet Res. 2019 Feb 26;15(1):65 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30808423 PMCID: PMC6390376 Free PMC article
- ↑ Meier A, Reiche D, de Laat M, Pollitt C, Walsh D, Sillence M. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies. PLoS One. 2018 Sep 13;13(9):e0203655. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30212530 PMCID: PMC6136744 Free PMC article